ES2576777B1 - Composition for the treatment of skin diseases and for veterinary use - Google Patents
Composition for the treatment of skin diseases and for veterinary use Download PDFInfo
- Publication number
- ES2576777B1 ES2576777B1 ES201400704A ES201400704A ES2576777B1 ES 2576777 B1 ES2576777 B1 ES 2576777B1 ES 201400704 A ES201400704 A ES 201400704A ES 201400704 A ES201400704 A ES 201400704A ES 2576777 B1 ES2576777 B1 ES 2576777B1
- Authority
- ES
- Spain
- Prior art keywords
- composition
- ointment
- topical administration
- mixture
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Abstract
Composición para administración tópica en forma de pomada que comprende en su formulación extracto de las flores de sauco (Sambucus nigra L.), extracto de romero (Rosmarinus officinalis), incienso, cera virgen de abeja y aceite de oliva, procedimiento para su preparación y su uso para el tratamiento de afecciones de la piel y para uso veterinario.Composition for topical administration in the form of an ointment comprising in its formulation extract of elder flowers (Sambucus nigra L.), rosemary extract (Rosmarinus officinalis), incense, virgin beeswax and olive oil, preparation procedure and its use for the treatment of skin conditions and for veterinary use.
Description
55
1010
15fifteen
20twenty
2525
Composition para el tratamiento de enfermedades cutaneas y para uso veterinario.Composition for the treatment of cutaneous diseases and for veterinary use.
DESCRIPCIONDESCRIPTION
Campo de la inventionField of the invention
La presente invention se refiere a una composition para administration topica en forma de pomada y a un procedimiento de fabrication de dicha composition, la cual comprende en su formulation como principios activos, extracto a partir de flores de sauco (Sambucus nigra L.) desechando los tallos y cortezas, extracto de romero (Rosmarinus officinalis), incienso, cera virgen de abeja y aceite de oliva.The present invention relates to a composition for topical administration in the form of an ointment and to a manufacturing process of said composition, which comprises in its formulation as active principles, extract from elder flowers (Sambucus nigra L.) discarding the stems and bark, rosemary extract (Rosmarinus officinalis), incense, virgin beeswax and olive oil.
La presente invention tambien se refiere al uso de la composition topica en forma de pomada para el tratamiento de la piel afectada por quemaduras, por irritation debido a la exposition al calor o al frio, danos ocasionados despues de tratamientos de radioterapia y quimioterapia, rozaduras, diferentes tipos de heridas producidas por cortes o pinchazos, escaras, llagas, picaduras de insectos. La pomada descrita en la presente invention tambien es aplicable al tratamiento de hemorroides, fistulas, escoceduras en las axilas y genitales, herpes, hongos, psoriasis, varicela, forunculosis, eccemas, granos infectados, uneros, dureza y sequedad de talones, manos y codos, para la hidratacion de la piel y el tratamiento de arrugas. La pomada descrita en la presente invention tambien tiene uso veterinario en el tratamiento de heridas en la piel de los animales.The present invention also relates to the use of the topical composition in the form of an ointment for the treatment of skin affected by burns, for irritation due to exposure to heat or cold, damage caused after radiotherapy and chemotherapy treatments, chafing, different types of wounds caused by cuts or punctures, bedsores, sores, insect bites. The ointment described in the present invention is also applicable to the treatment of hemorrhoids, fistulas, underarms and genital stings, herpes, fungi, psoriasis, chicken pox, furunculosis, eczema, infected, unerosal grains, hardness and dryness of heels, hands and elbows , for skin hydration and wrinkle treatment. The ointment described in the present invention also has veterinary use in the treatment of wounds on the skin of animals.
Antecedentes de la inventionBackground of the invention
La piel esta formada por tres capas superpuestas y separadas entre si: la epidermis, la dermis y la hipodermis constituyendo el organo vivo mas pesado y mas amplio del cuerpo humano, siendo la epidermis la capa mas externa.The skin is formed by three layers superimposed and separated from each other: the epidermis, the dermis and the hypodermis constituting the heaviest and widest living organ in the human body, the epidermis being the outermost layer.
Las funciones basicas de la piel son tres:The basic functions of the skin are three:
(a) proteger al cuerpo de ataques mecanicos, qulmicos, flsicos y de las infecciones por el ataque de microorganismos;(a) protect the body from mechanical, chemical, physical and infection attacks by microorganism attacks;
(b) constituye una red de comunicacion entre el cuerpo y el medio exterior gracias a una infinidad de terminaciones nerviosas que reciben todo tipo de estlmulos del exterior;(b) it constitutes a communication network between the body and the external environment thanks to an infinity of nerve endings that receive all kinds of external stimuli;
55
1010
15fifteen
20twenty
2525
3030
(c) constituye una barrera selectiva para el transporte de sustancias hacia el interior de nuestro cuerpo y la secrecion de sustancias nocivas a traves del sudor, ademas interviene en la slntesis de la vitamina D que juega un rol preponderante para el crecimiento de los huesos.(c) It constitutes a selective barrier for the transport of substances into our body and the secretion of harmful substances through sweat, it also intervenes in the synthesis of vitamin D that plays a preponderant role for bone growth.
La epidermis la forman cuatro capas de celulas: la capa basal (la mas profunda), la capa mucosa, la capa granular y el estrato corneo (la capa superior). El estrato corneo (EC) constituye una pellcula plana y continua formada por celulas ricas en queratinas (protelnas especializadas de la cubierta de los corneocitos) cuyas funciones son basicamente mecanicas y protectoras. Pasado un tiempo las celulas constituyentes EC pierden su vitalidad y mueren desprendiendose de la piel en forma de escamas mediante la exfoliacion.The epidermis is formed by four layers of cells: the basal layer (the deepest), the mucous layer, the granular layer and the corneal layer (the upper layer). The stratum corneum (EC) constitutes a flat and continuous film formed by keratin-rich cells (specialized proteins of the corneocyte shell) whose functions are basically mechanical and protective. After a while the EC constituent cells lose their vitality and die peeling off the skin in the form of scales by exfoliation.
Ademas de las queratinas, el EC esta constituido por llpidos, protelnas, factor natural de hidratacion, desmosomas (estructuras de adhesion especializadas) y enzimas.In addition to keratins, the EC is made up of lipids, proteins, natural hydration factor, desmosomes (specialized adhesion structures) and enzymes.
Los llpidos del EC entre los cuales se destacan las ceramidas, el colesterol y acidos grasos forman una barrera de permeable al agua.EC lipids, among which ceramides, cholesterol and fatty acids stand out, form a water permeable barrier.
El factor natural de hidratacion es una mezcla de aminoacidos, derivados de aminoacidos y sales especlficas que solo esta presente en el EC y su rol hidratante se debe a la solubilidad e higroscopicidad de sus componentes. En consecuencia con esto, el factor natural de hidratacion absorbe el agua tanto de la atmosfera, como del interior de la piel, previniendo descamacion anormal y el agrietamiento de la misma.The natural hydration factor is a mixture of amino acids, amino acid derivatives and specific salts that is only present in the EC and its hydrating role is due to the solubility and hygroscopicity of its components. Consequently, the natural hydration factor absorbs water from both the atmosphere and the inside of the skin, preventing abnormal flaking and cracking.
El funcionamiento correcto del EC en el mantenimiento de la suavidad, elasticidad y flexibilidad de la piel, depende de la interaction armonica de los llpidos, y el factor natural de hidratacion y de las concentraciones de los mismos.The correct functioning of the EC in maintaining the softness, elasticity and flexibility of the skin, depends on the harmonic interaction of the lipids, and the natural hydration factor and their concentrations.
La falta de hidratacion y las diversas lesiones epidermicas como quemaduras, eccemas, los danos producidos por psoriasis, etc, terminan produciendo heridas en la piel exponiendo nuestro cuerpo al ataque de agentes externos, como son las infecciones microbianas. Por esta razon es vital proporcionar los cuidados adecuados a la piel, para garantizar que la primera barrera que es el EC se mantenga de forma saludable.Lack of hydration and various epidermal lesions such as burns, eczema, damage caused by psoriasis, etc., end up causing skin wounds exposing our body to the attack of external agents, such as microbial infections. For this reason it is vital to provide adequate skin care, to ensure that the first barrier that is EC remains healthy.
55
1010
15fifteen
20twenty
2525
3030
El estado de la tecnica muestra diversas composiciones destinadas al cuidado de la piel, gran parte de las cuales incluyen ciertos farmacos sinteticos que actuan impidiendo la proliferation de los microorganismos en las lesiones provocadas por las quemaduras y otras afecciones cutaneas.The state of the art shows various compositions intended for skin care, many of which include certain synthetic drugs that act to prevent the proliferation of microorganisms in lesions caused by burns and other skin conditions.
Por ejemplo, la patente rumana n° RO 92445, describe una pomada para el tratamiento de quemaduras cutaneas, compuesta por subnitrato de bismuto, ictiol, oxido de cinc, alcanfor, aceite de Jecoris, acetato de vitamina A, vitamina F, acido ascorbico, acetato de hidrocortisona, sulfato de neomicina, lanolina y vaselina.For example, Romanian Patent No. RO 92445 describes an ointment for the treatment of skin burns, composed of bismuth subnitrate, ichthyol, zinc oxide, camphor, Jecoris oil, vitamin A acetate, vitamin F, ascorbic acid, hydrocortisone acetate, neomycin sulfate, lanolin and petrolatum.
La patente rusa n° RU 2.085.204 se refiere a un balsamo basado en aceite para la cura de heridas, que comprende mas del 0,33 % de alcanfor, mas del 0,3 % de un aceite concentrado (50 % aceite de menta y 50 % de aceites de otras plantas) y un extracto de aceite de distintas hierbas medicinales, como equilibrante.Russian Patent No. RU 2,085,204 refers to an oil-based balm for wound healing, comprising more than 0.33% camphor, more than 0.3% of a concentrated oil (50% peppermint oil and 50% of oils from other plants) and an extract of oil from different medicinal herbs, as a balancing agent.
La patente espanola ES2187253 se refiere a una pomada para quemaduras, herpes, eczemas y otras afecciones cutaneas, que consiste en una pomada preparada a base de hojas de hiedra comun (en particular hiedra macho), 100 g de hiedra comun macho, 100 g de cera virgen, en un decilitro de aceite de oliva.The Spanish patent ES2187253 refers to an ointment for burns, herpes, eczema and other skin conditions, which consists of an ointment made from common ivy leaves (in particular male ivy), 100 g of male common ivy, 100 g of virgin wax, in a deciliter of olive oil.
La patente espanola ES2186586 describe una pomada medicinal contra la psoriasis, que comprende en su formulation ortiga blanca (Lamium albium), marrubio blanco (Marrubium vulgare), culantrillo (Adiantum capillus veneris), espliego (Lavandula officinalis), bardana (Arctium lappa), incienso, vinagre de manzana, cera de abejas, manteca de cerdo, grasa de caballo, sebo de cordero, azufre y arcilla para su uso topico a fin de aliviar y eliminar los slntomas de la enfermedad.The Spanish patent ES2186586 describes a medicinal ointment against psoriasis, which comprises in its formulation white nettle (Lamium albium), white horn (Marrubium vulgare), culantrillo (Adiantum capillus veneris), lavender (Lavandula officinalis), burdock (Arctium lappa), Frankincense, apple cider vinegar, beeswax, lard, horse fat, lamb tallow, sulfur and clay for topical use to relieve and eliminate the symptoms of the disease.
Por otra parte, la patente espanola ES2443816 se refiere a una composition para el tratamiento de la dermatosis, especlficamente psoriasis, que contiene manzanilla, tomillo, laurel, lupulo, mijo, malta de cebada, levadura de cerveza, sauce, alhova (Trigonella foenum-graecum), salicaria (Lythrum salicaria); hibisco (Hibiscus) , aceite de oliva, miel de abeja, aloe vera, salvado de avena, achicoria, coparchy (Coutarea latifolia), Stevia, harina de trigo, cipres, malta de cerveza, lanolina, sauco, vara de oro (Solidago), Hamamelis; consuelda (Prunella vulgaris), y hierba de San Juan (Hypericum perforatum).On the other hand, the Spanish patent ES2443816 refers to a composition for the treatment of dermatosis, specifically psoriasis, which contains chamomile, thyme, bay leaf, hops, millet, barley malt, brewer's yeast, willow, alhova (Trigonella foenum- graecum), salicaria (Lythrum salicaria); Hibiscus (Hibiscus), olive oil, honey, aloe vera, oat bran, chicory, coparchy (Coutarea latifolia), Stevia, wheat flour, cypress, beer malt, lanolin, elder, goldenrod (Solidago) Witch hazel; Comfrey (Prunella vulgaris), and St. John's wort (Hypericum perforatum).
55
1010
15fifteen
20twenty
2525
Description de la inventionDescription of the invention
La composition dada a conocer en la presente invention comprende como principios activos extracto de las flores de sauco (Sambucus nigra L.) desechando los tallos y cortezas, extracto de romero (Rosmarinus officinalis), incienso, cera virgen de abeja y aceite de oliva.The composition disclosed in the present invention comprises as active ingredients elderflower extract (Sambucus nigra L.) discarding the stems and bark, rosemary extract (Rosmarinus officinalis), incense, virgin beeswax and olive oil.
Los efectos beneficiosos para el cuerpo humano de todos los componentes de la composition descrita son conocidos y la asociacion de los mismos segun la presente invencion permite, conseguir efectos curativos complejos y superiores, evitando el empleo de sustancias qulmicas sinteticas en ocasiones de diflcil adquisicion.The beneficial effects for the human body of all the components of the described composition are known and their association according to the present invention allows complex and superior curative effects to be achieved, avoiding the use of synthetic chemical substances at times of difficult acquisition.
A partir de los componentes mencionados anteriormente, se obtiene una mezcla homogenea segun el siguiente procedimiento:From the components mentioned above, a homogeneous mixture is obtained according to the following procedure:
a-) seleccionar flores de Sauco desechando los tallos y cortezas y pesar entre 0,1 - 5 g de flores de Sauco (Sambucus nigra L.), entre 0,1 - 5 g de romero (Rosmarinus officinalis), entre 1-50 g de incienso y 180 g de cera virgen de abeja.a-) select elder flowers by discarding the stems and barks and weigh between 0.1 - 5 g of elder flowers (Sambucus nigra L.), between 0.1 - 5 g of rosemary (Rosmarinus officinalis), between 1-50 g of incense and 180 g of virgin beeswax.
b-) verter 1 L de aceite de oliva con no mas de 1° de acidez en un recipiente apropiado que comprende un medio de agitation mecanica, un termometro, y un medio de intercambio termico y a continuation anadir las flores de sauco, el romero y el incienso pesados en la etapa a)b-) pour 1 L of olive oil with no more than 1 ° of acidity into an appropriate container comprising a mechanical agitation medium, a thermometer, and a thermal exchange medium and then add the elder flowers, rosemary and heavy incense in stage a)
c-) mantener la mezcla anterior con agitation continua hasta que se alcance una temperatura de 100 °C,c-) maintain the previous mixture with continuous stirring until a temperature of 100 ° C is reached,
d-) anadir 180 g de cera virgen de abeja a la mezcla obtenida en la etapa c-) y remover la mezcla hasta que se alcance una temperatura de 100 °C,d-) add 180 g of virgin beeswax to the mixture obtained in step c-) and stir the mixture until a temperature of 100 ° C is reached,
e-) filtrar la mezcla de la etapa d-), ye-) filter the mixture from step d-), and
f-) enfriar la mezcla hasta una temperatura entre 20 y 40 °C.f-) cool the mixture to a temperature between 20 and 40 ° C.
g-) envasar la mezcla.g-) pack the mixture.
Una vez que la mezcla final se enfrla, aumenta la consistencia de la misma hasta obtenerse una pomada estable que aplicada encima de la piel forma una capa homogenea.Once the final mixture cools, its consistency increases until a stable ointment is obtained that applied on top of the skin forms a homogeneous layer.
Todos los componentes de la pomada segun la invencion deben estar en estado puro, yAll components of the ointment according to the invention must be in a pure state, and
cumplir los requerimientos impuestos a las sustancias empleadas en productosmeet the requirements imposed on the substances used in products
55
55
1010
15fifteen
20twenty
2525
farmaceuticos. Por lo tanto, el aceite de oliva, por ejemplo, debe ser preparado justo antes de su utilization y, antes de ser empleado para la preparation de la pomada, es sometido a analisis. Dichos aceites son almacenados en recipientes cerrados, son enfriados y son mantenidos en un lugar oscuro. Ademas, ya no comprenden trazas de agua, para que se evite la turbidez de soluciones. Asimismo, la cera de abejas se purifica antes de su utilizacion.Pharmaceuticals Therefore, olive oil, for example, must be prepared just before its use and, before being used for the preparation of the ointment, is subjected to analysis. These oils are stored in closed containers, are cooled and kept in a dark place. In addition, they no longer include traces of water, so that the turbidity of solutions is avoided. Also, beeswax is purified before use.
Los componentes activos de la pomada, segun la invention, se activan uno al otro de forma reclproca y por lo tanto producen un efecto de sinergia en el tratamiento de algunas enfermedades cutaneas o de quemaduras cutaneas. Cuando se compara dicha pomada con productos analogos conocidos, se pueden apreciar varias ventajas, entre las que se pueden mencionar una action rapida, produciendo sus efectos curativos notables en un perlodo menor de 7 dlas para la mayorla de las afecciones cutaneas, proporciona un efecto bacteriostatico y fungicida, y no contiene sustancias sinteticas, que pudieran no estar disponibles. La pomada no debe aplicarse sobre la piel de personas que presente alergia a alguno de sus componentes.The active components of the ointment, according to the invention, activate each other reciprocally and therefore produce an effect of synergy in the treatment of some skin diseases or skin burns. When such ointment is compared with known analogue products, several advantages can be appreciated, among which a rapid action can be mentioned, producing its remarkable curative effects in a period less than 7 days for the majority of skin conditions, provides a bacteriostatic effect. and fungicide, and does not contain synthetic substances, which may not be available. The ointment should not be applied to the skin of people who are allergic to any of its components.
A continuation, se proporcionan ejemplos de la preparacion de la pomada segun la invencion, con el fin de explicar la invencion con mas detalle.Next, examples of the preparation of the ointment according to the invention are provided, in order to explain the invention in more detail.
Ejemplos de realizationRealization Examples
Los siguientes ejemplos especlficos que se proporcionan aqul sirven para ilustrar la naturaleza de la presente invencion. Estos ejemplos se incluyen solamente con fines ilustrativos y no han de ser interpretados como limitaciones a la invencion que aqul se reivindica.The following specific examples provided herein serve to illustrate the nature of the present invention. These examples are included for illustrative purposes only and are not to be construed as limitations to the invention claimed herein.
Ejemplo 1: Pomada para tratamiento de quemaduras de primer grado, cortes y heridas levesExample 1: Ointment for treatment of first degree burns, cuts and minor injuries
Como un ejemplo preferente de la presente invencion, pero no limitativo, se obtiene una pomada homogenea segun el siguiente procedimiento:As a preferred example of the present invention, but not limiting, a homogeneous ointment is obtained according to the following procedure:
a-) seleccionar flores de Sauco desechando los tallos y cortezas y pesar 2 g de flores de Sauco (Sambucus nigra L.), 2 g de romero (Rosmarinus officinalis), 50 g de incienso y 180 g de cera virgen de abeja.a-) select elder flowers by discarding the stems and barks and weigh 2 g of elder flowers (Sambucus nigra L.), 2 g of rosemary (Rosmarinus officinalis), 50 g of incense and 180 g of virgin beeswax.
55
1010
15fifteen
20twenty
2525
b-) verter 1 L de aceite de oliva con 1° de acidez en un recipiente apropiado que comprende un medio de agitacion mecanica, un termometro, y un medio de intercambio termico y a continuacion anadir las flores de sauco, el romero y el incienso pesados en la etapa a)b-) pour 1 L of olive oil with 1 ° of acidity into an appropriate container comprising a mechanical stirring medium, a thermometer, and a thermal exchange medium and then add the heavy elder flowers, rosemary and incense in stage a)
c-) mantener la mezcla anterior con agitacion continua hasta que se alcance una temperatura de 100 °C,c-) keep the previous mixture with continuous stirring until a temperature of 100 ° C is reached,
d-) anadir 180 g de cera virgen de abeja a la mezcla obtenida en la etapa c-) y remover hasta que se alcance una temperatura de 100 °C,d-) add 180 g of virgin beeswax to the mixture obtained in step c-) and stir until a temperature of 100 ° C is reached,
e-) filtrar la mezcla de la etapa d-), ye-) filter the mixture from step d-), and
f-) enfriar la mezcla hasta una temperatura entre 40 y 60 °C.f-) cool the mixture to a temperature between 40 and 60 ° C.
g-) envasar.g-) pack.
Despues de 15 min de su preparation aumenta la consistencia de la pomada hasta obtenerse una pomada estable que aplicada encima de la piel forma una capa homogenea.After 15 min of its preparation, the consistency of the ointment increases until a stable ointment is obtained which, applied on top of the skin, forms a homogeneous layer.
La pomada obtenida se aplica topicamente sobre una quemadura, cortes y heridas leves, presentando cicatrization completa del perlmetro tratado y regeneration epitelial a partir de las 12 horas.The ointment obtained is applied topically on a burn, cuts and minor wounds, presenting complete scarring of the treated perimeter and epithelial regeneration after 12 hours.
Ejemplo 2: Pomada para tratamiento de quemaduras de segundo grado, cortes y heridas gravesExample 2: Ointment for treatment of second degree burns, cuts and serious wounds
Se obtiene una pomada homogenea segun el ejemplo 1.A homogeneous ointment is obtained according to example 1.
Antes de la aplicacion de la pomada conviene retirar la piel muerta o ampolla, que se produce por la quemadura de segundo grado se realiza una la limpieza con una gasa para eliminar la piel muerta o ampollas. A continuacion se impregna una gasa de algodon con la pomada y se mantiene aplicada sobre la zona afectada para realizar la cura. Las curas se repiten cada 24 horas. A partir del cuarto dla de tratamiento se observan efectos curativos ya que se regenera la piel quemada sin dejar cicatriz.Before the application of the ointment, it is advisable to remove the dead skin or blister, which is caused by the second degree burn, a cleaning is done with gauze to remove dead skin or blisters. Subsequently, a cotton gauze is impregnated with the ointment and kept applied on the affected area to perform the cure. The priests are repeated every 24 hours. From the fourth day of treatment curative effects are observed since the burned skin is regenerated without leaving a scar.
Si al producir una quemadura se trata con la pomada en los 2 minutos posteriores como maximo, no se producen ampollas en la zona quemada evitando de esta manera la necesidad de hacer la limpieza inicial.If, when producing a burn, the ointment is treated within a maximum of 2 minutes, no blisters occur in the burned area, thus avoiding the need for initial cleaning.
Para el caso de heridas y cortes se procede de manera similar. Despues de desinfectar la zona afectada, se aplica la pomada mediante una gasa. Se repite el tratamiento cada 24 horas. A partir del cuarto dla se observan los efectos cicatrizantes.In the case of wounds and cuts, the procedure is similar. After disinfecting the affected area, the ointment is applied by gauze. The treatment is repeated every 24 hours. From the fourth day the healing effects are observed.
5 Ejemplo 3: Pomada para tratamiento de lesiones producida por eccemas, hemorroides, psoriasis, hongos y herpes.5 Example 3: Ointment for the treatment of lesions caused by eczema, hemorrhoids, psoriasis, fungi and herpes.
Se obtiene una pomada homogenea segun el ejemplo 1.A homogeneous ointment is obtained according to example 1.
La pomada obtenida se aplica topicamente sobre varias lesiones en diferentes zonas corporales que presentan psoriasis, eccemas, hemorroides u hongos presentando 10 cicatrizacion completa, alivio, hidratacion y elimination de la afeccion de la zona afectada en un periodo menor a los 10 dlas.The ointment obtained is applied topically on several lesions in different body areas that present with psoriasis, eczema, hemorrhoids or fungi, presenting complete healing, relief, hydration and elimination of the affected area in a period less than 10 days.
En el caso de herpes, a partir de las 12 horas se notan mejorlas y en 48 horas desaparece.In the case of herpes, after 12 hours improvements are noticed and within 48 hours it disappears.
Ejemplo 4 : Pomada para uso veterinario.Example 4: Ointment for veterinary use.
Se obtiene una pomada homogenea segun el ejemplo 1.A homogeneous ointment is obtained according to example 1.
15 La pomada obtenida se aplica sobre la piel de animales en heridas ocasionadas por alambres y aparejos, produciendose un efecto desinfectante y regenerador a partir de las 12 horas. Las heridas desaparecen al cabo de una semana, aplicando la pomada cada 24 horas.15 The ointment obtained is applied to the skin of animals in wounds caused by wires and rigging, producing a disinfectant and regenerating effect after 12 hours. The wounds disappear after a week, applying the ointment every 24 hours.
20twenty
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201400704A ES2576777B1 (en) | 2015-01-09 | 2015-01-09 | Composition for the treatment of skin diseases and for veterinary use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201400704A ES2576777B1 (en) | 2015-01-09 | 2015-01-09 | Composition for the treatment of skin diseases and for veterinary use |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2576777A1 ES2576777A1 (en) | 2016-07-11 |
ES2576777B1 true ES2576777B1 (en) | 2017-02-14 |
Family
ID=56320638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES201400704A Active ES2576777B1 (en) | 2015-01-09 | 2015-01-09 | Composition for the treatment of skin diseases and for veterinary use |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2576777B1 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2056029B1 (en) * | 1993-03-02 | 1995-04-01 | Vitores Raquel Maria Iglesias | COMPOSITION OF A PRODUCT FOR SKIN REGENERATION. |
ES2095192B1 (en) * | 1995-05-23 | 1997-09-01 | Ezquerra Gomez Isabel | OIL FOR BURNS. |
RO113113B1 (en) * | 1997-05-07 | 1999-04-30 | Felician Titus Stoica | Ointment for treating burns and other skin affections |
ES2138939B1 (en) * | 1998-07-14 | 2000-10-01 | Herrero Gonzalez Jose Luis | OIL FOR BURNS. |
ES2176114B1 (en) * | 2001-03-27 | 2003-11-01 | Vila Falco M Dolores | MOISTURIZING PUMP FOR BURNS |
GR1004069B (en) * | 2001-10-03 | 2002-12-19 | Γεωργιου Ιωαννης Σταθοπουλος | Method for the preparation of a medicinal ointment or cream curing burns produced by fire |
US20040208943A1 (en) * | 2003-04-21 | 2004-10-21 | Bronhilda Miketin | Method for treatment of skin disorders |
-
2015
- 2015-01-09 ES ES201400704A patent/ES2576777B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2576777A1 (en) | 2016-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070098671A1 (en) | Composition and method of treatment for irritated skin | |
ES2492672T3 (en) | Collagen for use in the treatment of skin diseases | |
JP2011507845A5 (en) | ||
KR102096414B1 (en) | Cosmetic composition for improving of acne skin | |
JP5965393B2 (en) | Kit of parts for treating and / or preventing skin ulcers | |
CN102283899B (en) | Traditional Chinese medicine external preparation and application thereof | |
CN104666496A (en) | Menthol ointment and preparation process thereof | |
US20200330543A1 (en) | A topical herbal healing formulation | |
IT201900000385A1 (en) | COMPOSITION FOR THE TREATMENT OF SKIN INJURIES AND IRRITATIONS | |
WO2016029328A1 (en) | Pharmaceutical composition for preventing, treating, and curing psoriasis including snail slime, chamomile, and honey | |
ES2684519T3 (en) | Dermatological composition based on algae and olive leaf extracts | |
WO2016054757A1 (en) | Pharmaceutical composition for preventing, treating and curing rosacea, comprising snail slime, camomile and propolis | |
ES2576777B1 (en) | Composition for the treatment of skin diseases and for veterinary use | |
JP7411266B2 (en) | Colloidal silver in combination with plant extracts used to treat wounds and other skin conditions | |
ES2416804A1 (en) | Composition of natural products for topical application | |
RU2611400C2 (en) | Wound healing gel for external application | |
TWM610166U (en) | Microcapsule structure | |
Khaleghverdi et al. | The Effect of Myrtus, Honey, Aloe Vera and Pseudomonas Phage Treatment on Infected Second Degree Burns: In Vivo Study | |
ITMI941680A1 (en) | VEGETABLE EXTRACT AGAINST BURNS | |
US20140127315A1 (en) | Caudal Salve | |
RU2287995C1 (en) | Wound-healing preparation (variants) | |
RU2760838C1 (en) | Method for treating burns of degree 3a by applying glauconite powder | |
WO2018188197A1 (en) | Antibacterial and anti-inflammatory drug and preparation method therefor | |
MX2013004077A (en) | Pharmaceutical composition based on centella asiatica (hydrocotyle asiatica l.) for treating lower limbs ulcers. | |
RU2782695C1 (en) | Composition for external use "septisol" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 2576777 Country of ref document: ES Kind code of ref document: B1 Effective date: 20170214 |